![]() |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|
|
![]() Mannatech's products are based on the company's proprietary technology, which it calls Glyconutrition. Glyconutrition is the study of carbohydrates and their impact on human health. The company's products are marketed under the Mannatech brand and are sold through a network of independent distributors and associates. Mannatech's product line includes Ambrotose, a dietary supplement that contains a blend of plant polysaccharides; Omega-3 with Vitamin D3, a fish oil supplement; and Emprizone, a skin care product line. In addition to its products, Mannatech offers a business opportunity for individuals who want to become independent distributors of the company's products. Distributors earn commissions on their sales and can also earn bonuses based on the sales of their downline distributors. Mannatech has faced legal challenges over the years. In 2007, the company settled with the Texas Attorney General's office over allegations of false advertising. In 2009, the company settled with the Securities and Exchange Commission over charges of accounting irregularities. As of September 2021, Mannatech had a market capitalization of approximately $67 million.
|
||||||||||||
|
||||||||||||
|
||||||||||||
|